Lv2
110 积分 2021-06-01 加入
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
1天前
待确认
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
6天前
已完结
In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation
7天前
已完结
Toward In Vivo CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design
7天前
已完结
Lipid nanoparticles for mRNA delivery
7天前
已完结
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia
9天前
已完结
Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma
9天前
已完结
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial
9天前
已完结
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
21天前
已关闭
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia
21天前
已完结
皖公网安备34019202002308
